Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,381 | -28,286 | -104,787 | -78,608 | -55,888 |
| Depreciation Amortization | 199 | 100 | 357 | 260 | 169 |
| Accounts payable and accrued liabilities | 1,251 | 307 | 351 | -9 | 97 |
| Other Working Capital | -1,814 | 3,707 | 3,022 | 1,267 | 1,042 |
| Other Operating Activity | 6,238 | 3,781 | 18,992 | 14,736 | 10,218 |
| Operating Cash Flow | $-42,507 | $-20,391 | $-82,065 | $-62,354 | $-44,362 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -363 | -190 | -51 |
| Purchase Of Investment | -74,760 | -24,373 | -213,660 | -169,167 | -150,720 |
| Sale Of Investment | 126,260 | 61,760 | 305,502 | 244,500 | 205,750 |
| Investing Cash Flow | $51,500 | $37,387 | $91,479 | $75,143 | $54,979 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,263 | 220 | 476 | 203 | 97 |
| Financing Cash Flow | $2,263 | $220 | $476 | $203 | $97 |
| Beginning Cash Position | 23,702 | 23,702 | 13,812 | 13,812 | 13,812 |
| End Cash Position | 34,958 | 40,918 | 23,702 | 26,804 | 24,526 |
| Net Cash Flow | $11,256 | $17,216 | $9,890 | $12,992 | $10,714 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,507 | -20,391 | -82,065 | -62,354 | -44,362 |
| Capital Expenditure | N/A | N/A | -363 | -190 | -51 |
| Free Cash Flow | -42,507 | -20,391 | -82,428 | -62,544 | -44,413 |